AbbVie has announced positive results from two replicate Phase 3 clinical trials of Elagolix in premenopausal women with endometriosis.
The Food and Drug Administration (FDA) reports the discontinuation of Menest (esterified estrogens; Pfizer) 2.5mg tablets.
A new study of over 56,000 women found that those who purchased antidepressants at least twice during pregnancy had a 37% increased risk of speech and/or language disorder in their offspring compared to mothers who were not treated with antidepressants.
Par announced a voluntary recall of certain lots of Gildess, Gildess FE, and Gildess 24 FE products.
Progestin-containing intrauterine device (IUD) was deemed safe and acceptable as a long-acting contraceptive for women with epilepsy, a study published in Epilepsia has found.
As regulatory status of levonorgestrel emergency contraception has changed over the years, there has been increased confusion about how emergency contraception can be sold.
For women with type 1 diabetes, elevated fatty acid binding protein 4 (FABP4) in early pregnancy and in the second trimester is associated with subsequent preeclampsia, according to a study published online September 14 in Diabetes Care.
The FDA has accepted for review the New Drug Application (NDA) for Yuvvexy (17β-estradiol; TherapeuticsMD) for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar vaginal atrophy (VVA) in postmenopausal women.
Bayer announced that the Food and Drug Administration (FDA) has approved Kyleena (levonorgestrel-releasing intrauterine system) for the prevention of pregnancy for up to 5 years.
Data from a pilot randomized trial published in Nicotine & Tobacco Research showed that administering exogenous progesterone may potentially prevent postpartum smoking relapse.
The Food and Drug Administration (FDA) has issued a safety alert regarding the use of screening tests for ovarian cancer screening.
Ovarian cancer mortality is down dramatically in many parts of the world, and the use of oral contraceptives (OCs) may be a main reason why, according to a study published online in the Annals of Oncology.
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to SAGE-547 (Sage Therapeutics) for the treatment of postpartum depression (PPD).
Even though most new mothers in the United States begin breastfeeding their infants at birth, many stop sooner than recommended, according to the 2016 Breastfeeding Report Card from the U.S. Centers for Disease Control and Prevention.
Daily vaginal progesterone initiated at 16 weeks was a reasonable alternative to weekly 17-alpha-hydroxy-progesterone caproate (17-OHPC) for the prevention of spontaneous preterm birth in women with singleton gestations and prior spontaneous preterm birth, a systematic review in Obstetrics & Gynecology reported.
A review published in the Cochrane Database of Systematic Reviews generally found no association between higher body mass index (BMI) or weight and hormonal contraceptive efficacy.
Monogenic forms of diabetes can occur in preterm infants, according to a study published online in Pediatrics.
Use of antipsychotics (APs) in pregnancy does not appear to increase the risk for congenital malformations, according to a study published online in JAMA Psychiatry.
Antenatal administration of corticosteroids is not associated with a reduction in the incidence of respiratory distress syndrome (RDS) in preterm twins, according to research published in the September issue of Obstetrics & Gynecology.
Compared with current recommendations from professional societies, expanded carrier screening may increase the detection of carrier status for potentially serious genetic conditions, according to a study published in the Journal of the American Medical Association.
Onsite tests have high specificity for detecting asymptomatic bacteriuria among pregnant women, but sensitivity is lower, according to a review published in the September issue of Obstetrics & Gynecology.
Patients undergoing fertility treatment often suffer symptoms of depression or anxiety, but few get any formal help, according to research published in Fertility and Sterility.
An expert panel has proposed clinical guidelines for diagnosing fetal alcohol syndrome disorder (FASD), expanding upon the first guidelines from 2005 that helped distinguish the four subtypes of FASD.
Researchers from the National Institute of Environmental Health Sciences in Research reported that women risk having their vitamin D levels drop when they cease using contraceptives containing estrogen.
Consuming soy isoflavones may improve cardiovascular and metabolic health in women with polycystic ovary syndrome (PCOS), results from a new study in the Journal of Clinical Endocrinology & Metabolism has found.
Women with vaginal mesh with complications have a significantly increased proinflammatory response, according to a study published in the American Journal of Obstetrics & Gynecology.
Virtus has announced the launch of Prometrium (progesterone USP capsule).
The Centers for Disease Control and Prevention (CDC) released an update to the 2013 U.S. Selected Practice Recommendations for Contraceptive Use guideline after review of scientific data and expert consultation.
Obstetrician-gynecologists should counsel pregnant women about use of long-acting reversible contraception (LARC), such as implants and intrauterine devices (IUDs), immediately after they give birth, according to an American College of Obstetricians and Gynecologists (ACOG) Committee Opinion published in Obstetrics & Gynecology.
A bracelet that can track a woman's fertility has been launched today by the medical technology company Ava. In clinical trials the bracelet (which is worn only at night), detected an average of 5.3 fertile days per cycle with 89% accuracy.
Although evidence is limited, a new systematic review in Contraception indicates a greater risk of ovulation and breakthrough as well as reduced contraceptive efficacy when combined oral contraceptives (COCs) are co-administered with St. John's wort.
Inducing labor won't raise a pregnant woman's risk of having a child with autism, according to a study published online JAMA Pediatrics.
U.S. health officials on Monday updated their Zika virus guidelines, saying that pregnant women could contract Zika from a sex partner of either gender.
A new study has deemed that concern for clinically significant drug interactions between hormonal contraceptives (HC) and psychotropic drugs is low; however, the authors of the study did assert that more research is needed in this area.
Nanohealth announced the launch of the nanopause Bolero, a non-hormone product cleared by the Food and Drug Administration (FDA) to relieve symptoms of menopause such as hot flashes and night sweats.
Improvement in cognitive ability is not associated with estrogen therapy among women who use it after menopause, no matter when they start taking it, according to a study published online in Neurology.
Women who undergo in vitro fertilization (IVF) are not at increased risk of breast cancer, according to a study published in the issue of the Journal of the American Medical Association.
Decreasing caffeine intake may not help women prevent premenstrual syndrome (PMS), a team of researchers reported.
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are associated with increased odds of bulimia nervosa (BN), but not with binge-eating disorder (BED), according to a study published in the July issue of the International Journal of Eating Disorders.
Continuation rates for intrauterine devices (IUDs) were generally higher vs. other contraceptive methods for women aged ≤25 years.
The diagnosis and management of polycystic ovary syndrome is discussed in a case vignette published online in The New England Journal of Medicine.
A patient-reported study of hormonal contraceptives has found a significantly varied effect on acne among commonly prescribed agents.
Breastfeeding premature infants appears to increase the likelihood that those infants will have healthier hearts in young adulthood, according to research published online in Pediatrics.
Among women with asymptomatic undiagnosed cervical infection or who are at high risk of sexually transmitted infections (STIs), intrauterine device (IUD) placement does not increase the risk of pelvic inflammatory disease (PID) compared with no IUD placement, a study published in Contraception has found.
New research suggests that the antiepileptic drug (AED) topiramate, when used in combination with other AEDs (excluding valproate) may enhance its propensity to cause fetal malformation.
Symbiomix announced positive results from the second pivotal Phase 3 trial of SYM-1219 (secnidazole) for the treatment of bacterial vaginosis (BV).
Prolactin receptor (PRLR) signaling plays a role in expansion of maternal β-cells during pregnancy, according to a study published online in Diabetes.
In the most definitive study to date, cigarette smoking during pregnancy was linked to a greater likelihood of schizophrenia in offspring. Those are the findings of a new long-term study which assessed maternal nicotine exposure (via cotinine levels) during pregnancy.
Researchers from Johns Hopkins Bloomberg School of Public Health reported that too much folate in a new mother's body may increase a child's risk of developing an autism spectrum disorder. Findings from the study will be presented at the 2016 International Meeting for Autism Research.
An updated Cochrane review found low or very low quality evidence.
Lupin Pharmaceuticals has announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH).
The Food and Drug Administration (FDA) is advising caution when prescribing oral fluconazole (Diflucan) in pregnancy after evaluating data from a Danish study that indicated a possible increased risk of miscarriage when used to treat yeast infections.
Hospira announced a voluntary recall of one lot of 50% Magnesium Sulfate Injection, 10g/20mL (0.5/gmL), 20mL single-dose vials.
A Cochrane review found no high quality evidence to support the efficacy of any dietary supplement for dysmenorrhea.
According to a study published in Neurology, babies born to pregnant women taking lamotrigine may not be at an increased risk of birth defects, such as a cleft lip, cleft palate or clubfoot.
The Society for Maternal-Fetal Medicine (SMFM) issued a statement on the use of antenatal corticosteroids during the late preterm birth period for women at risk of preterm birth.
Selective serotonin reuptake inhibitors (SSRIs) use during pregnancy and lactation can result in decreased bone density in mothers, increasing their risk of fractures later in life, a study presented at ENDO 2016 has found.
Polycystic ovary syndrome (PCOS) and excess weight have been independently linked with the onset of asthma, according to findings in a new study to be presented at the annual Endocrine Society meeting.
Radius Health announced the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for abaloparatide-subcutaneous (SC) 80mg, a once daily treatment for postmenopausal women with osteoporosis.
The Endocrine Society has issued a statement advising clinicians to avoid administering compounded hormone medications to treat menopausal symptoms, female sexual dysfunction, and other hormone conditions.
Expecting mothers should make sure they get enough vitamin D exposure during the second trimester to reduce the child's likelihood of developing asthma, according to new research by the University of Kansas published in the American Journal of Health Economics.
Researchers from Western Australia reported that seasonal influenza vaccinations may protect against stillbirth.
Drugs that were once considered safe for pregnant women with migraines may not be, according to researcher at Wake Forest Baptist Medical Center.
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Mifeprex (mifepristone; Danco Laboratories) including modifications to the risk evaluation and mitigation strategy (REMS) assessment.
Researchers from the National Institutes of Health and Ohio State University report that the risk of miscarriage increases if couples consume over two caffeinated beverages a day in the weeks leading up to conception.
In women who use oral contraceptives, obesity is a strong risk factor for cerebral venous thrombosis.
Strides are being made toward the development of a male oral contraceptive. Researchers at the University of Minnesota are making tweaks to experimental compounds already developed by the drug company Bristol-Myers Squibb (BMS), to produce a safe, soluble and fast-acting male contraceptive.
Duchesnay announced the launch of Mteryti and Mteryti folic 5 products to help optimize iron, calcium, and folic acid absorption for prenatal use.
In a new draft guidance, the Food and Drug Administration (FDA) announced that they have ordered Bayer to conduct follow-up studies for their permanent form of birth control, Essure.
How safe and effective is flibanserin (Addyi; Valeant) for the treatment of hypoactive sexual desire disorder (HSDD) in women?
A new review article explores the current research findings of perimenopausal women's symptoms and the treatment options available to reduce the impact they may have on quality of life.
Vertical Pharmaceuticals announced the launch of OB Complete Gold, prenatal vitamins providing the first egg-based docosahexaenoic acid (DHA).
Infants whose mothers took atazanavir had small but significant effects on language and social-emotional development, compared to other non-atazanavir-containing antiretroviral regimens, a study published in AIDS has shown.
A study found that 30% of women with epilepsy did not use highly effective contraception though they are at an increased risk of having babies with fetal malformations due to their antiepileptic medications.
AbbVie and Neurocrine Biosciences announced positive top-line results from the second of two replicate Phase 3 clinical trials of Elagolix in premenopausal women with endometriosis-associated pain.
Serologic testing for Zika virus has been recommended in asymptomatic pregnant women, who have traveled to, or reside in, areas of ongoing transmission.
Authors of a new study argue their findings provide sufficient evidence to change standard skin-prep practices for C-sections, in order to avoid the ongoing risk of infection.
Early treatment with oseltamivir may reduce length of hospital stay for pregnant women with the flu, especially for severe cases, a new study reported.
The U.S. Centers for Disease Control and Prevention (CDC) has called for an increase in research on the potential risks of taking antidepressants during pregnancy.
Two new trials have found no significant statistical reduction in cases of persistent wheezing and asthma where the mother had taken additional vitamin D supplements.
Taking certain asthma medication during pregnancy could increase the risk of the child being diagnosed with autism spectrum disorder.
A new study has found that women who take oral contraceptives just before or during pregnancy do not have an increased risk of birth defects.
Using the oral antifungal medication fluconazole during pregnancy has been associated with an increased risk of spontaneous abortion.
Hospira announced a voluntary recall of one lot of Magnesium Sulfate in Water for Injection (0.235mEq Mg/mL) 40mg/mL 2g total, 50mL due to a potentially incorrect barcode.
Using the antidepressant paroxetine during the first trimester of pregnancy may increase the risk of major congenital and cardiac malformations in newborns.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments.
Metformin may potentially help prevent and treat preeclampsia, according to a study published in the American Journal of Obstetrics and Gynecology.
A large-scale study has found a link between antidepressant (AD) use during the second and/or third trimester of pregnancy and an increased risk of autism spectrum disorder (ASD) in children by 87%.
Young males whose mothers smoked during pregnancy had lower aerobic fitness compared to males whose mothers did not smoke, according to a study published in BJOG: an International Journal of Obstetrics and Gynaecology.
A Phase 3 Rejoice Trial of TX-004HR (estradiol) to treat moderate to severe dyspareunia (vaginal pain during sexual intercourse), has had positive top-line results.
A Phase 2 clinical trial has shown how the pregnancy hormone estriol can help patients with relapsing-remitting multiple sclerosis (RRMS) avoid relapses.
The United States Preventive Services Task Force (USPSTF) released its annual Report to Congress reporting on 5 high-priority evidence gaps regarding women's health.
Healthy weight management before getting pregnant and appropriate weight gain during pregnancy significantly reduce the risk of infant death.
Compared to those who had not been on oral contraceptives, patients who had taken the pill had improved progression-free survival as well as overall survival.
A new study has found that the two most commonly prescribed antibiotics are not associated with an increased risk of adverse outcomes in pregnant women.
Ob-Gyns may help lower unintended pregnancy rates by increasing access to contraceptive implants and intrauterine devices (IUDs) for patients, according to a Committee Opinion paper released by ACOG.
The American Academy of Pediatrics (AAP) has issued a new clinical report in the November issue of Pediatrics emphasizing that no amount of alcohol should be considered safe to drink during any trimester of pregnancy due to the risk of fetal alcohol spectrum disorders (FASDs).
Sprout announced that that Addyi (flibanserin) tablets are now available for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Research in the American Society for Microbiology's journal Antimicrobial Agents and Chemotherapy found that pregnant women taking antiviral medications to treat hepatitis C (HCV) and/or HIV with non-steroidal anti-inflammatories (NSAIDs) or antihypertensives may have an increased risk of birth defects or stunted fetal growth, although these antiviral drugs have not been shown to directly cause harm to a fetus.